Medicine
Nexavar 200 mg tablet
Nexavar 200 mg tablet is a prescription medicine containing Sorafenib for oral use, marketed by Bayer HealthCare Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25° C (68°F to 77° F), excursions permitted to 15°C to 30° C…
Key facts
- Active ingredient (INN)
- Sorafenib
- Brand
- Nexavar
- Strength
- 200 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 120 tablets
- Marketing authorisation holder
- Bayer HealthCare Pharmaceuticals
- Manufacturer
- Bayer HealthCare Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25° C (68°F to 77° F), excursions permitted to 15°C to 30° C (59°F to 86° F). Store in a dry place.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01EX02 Sorafenib
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 December 2005
- Identifiers
- RxCUI 597747, 615979DailyMed set ID b50667e4-5ebc-4968-a646-d605058dbef0NDC 50419-488, 50419-489Application NDA021923
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 120 tablet, film coated in 1 bottle, plastic | 50419-488-58 | Bayer HealthCare Pharmaceuticals | 20 December 2005 |
| 120 tablet, film coated in 1 bottle, plastic | 50419-489-01 | Bayer HealthCare Pharmaceuticals | 2 October 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sorafenib 200 mg tablet.
Clinical summary
Sorafenib is a kinase inhibitor indicated for the treatment of unresectable hepatocellular carcinoma, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Sorafenib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SorafenibFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Nexavar prescribing information (Bayer HealthCare Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Nexavar: European public assessment report (EPAR) · European Medicines Agency
- Sorafenib Accord: European public assessment report (EPAR) · European Medicines Agency
Need Nexavar 200 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.